糖尿病是一種以高血糖為主要特征的慢性疾病，Ⅰ型或嚴重的Ⅱ型糖尿病患者往往需要皮下注射胰島素來維持血糖穩(wěn)定。由于過量的胰島素可能導致低血糖，甚至危及生命，因此每日通常需要分2~4次注射，給糖尿病患者的日常生活帶來巨大不便。因此，設計具有葡萄糖響應性能的胰島素遞送體系，根據(jù)血糖濃度智能地控制胰島素釋放速率，對減少給藥次數(shù)、方便患者生活具有重要意義。
Figure 1. The designing process of glucose-responsive microneedle patch with enhanced insulin-loading capacity and blood-glucose regulating performance.
Figure 2. (a) Self-assembly of polymers and the INS-loading process. (b) ILCs of the polymers under the feed ratio of 1 g/g. (c) ILCs of PL-NA/FPBA under the feed ratio of 1 g/g. (d) ILCs of PL-NA(20%)/FPBA(38%) under different feed ratios. (e) ILCs (average) of different polymeric carriers in the previous reports. The carriers were labeled according to their main chains, including βCD, Alg, pAsp, HA, CS, Dex, PLGA and αPL. The data of “PL” referred to ILC of PL-NA(20%)/FPBA(38%) under the feed ratio of 2 g/g. The data of (b)-(d) were shown as the means ± SD (n = 3).
Figure 4. (a) The reaction between NANP and glucose. (b) The glucose-responsive INS-releasing mechanism of INS/NANP and (c) the corresponding in-vitro cumulative-releasing profiles. (d) The glucose-responsive INS-releasing mechanism of NA-MNP and (e) the corresponding in-vitro cumulative-releasing profiles. The data of (c) and (e) were shown as the means ± SD (n = 3).
Figure 5. (a) The applied MNP on a rat with the skin repairing test (scale bar = 2 mm) and the trypan-blue staining test. (b) The 8-hour BGL-lowering test and (c) the corresponding BGL-lowering speeds (n = 5). (d) The 8-hour curves of plasma INS and (e) the calculation results of AUC (n = 5). (f) The hypoglycemia-avoiding test and (g) the calculation results of AUCHealth control (n = 5). (h) The IPGTT results (n = 5). (i) The curves of plasma INS (n = 5). (j) The BGL-monitoring procedure and (k) the corresponding BGL curves under the “three-meal-per-day” mode (n = 5). The data of (b-i, k) were shown as the means ± SD. The statistical analyses were performed by two-tailed Student’s t-test. The t-test of (h) was applied between “nNA-MNP” and “NA-MNP”. * P < 0.05, ** P < 0.01 and *** P < 0.001.
論文信息：ACS Appl. Mater. Interfaces 2023, 15, 31330-31343
論文鏈接：https://doi.org/10.1021/acsami.3c06483
- 吉林大學林權(quán)教授團隊 CEJ：葡萄糖響應性水凝膠優(yōu)化芬頓反應以根除多重耐藥細菌促進感染型糖尿病傷口愈合 2024-04-14
- 浙大王立教授和俞豪杰教授團隊 ACS AMI：用于糖尿病治療的靜電作用增強的葡萄糖響應胰島素遞送微針貼 2024-02-09
- 浙大王立教授和俞豪杰副教授團隊 J. Control. Release：基于分子對接技術(shù)設計的用于胰島素遞送的葡萄糖響應納米粒子 2023-01-06
- 南華大學劉陽團隊 IJBM：一種單寧酸交聯(lián)的基于苯硼酸改性羧甲基殼聚糖的多功能水凝膠 2025-02-23
- 南京大學蔣錫群/武偉團隊JACS：苯硼酸修飾可顯著增強蠕蟲狀聚合物分子刷前藥的溶酶體逃逸和抗腫瘤性能 2021-12-06
- 西安交大成一龍研究員與李昂教授《AFM》: 基于茶多酚與苯硼酸絡合物構(gòu)建的新型水凝膠傷口敷料 2021-02-04
- 東南大學葛麗芹教授課題組《ACS AMI》：微波響應工程化血小板微針貼片用于腫瘤深層滲透和精準治療 2025-02-26
